Google Alert - cannabidiol for epilepsy

	cannabidiol for epilepsy Daily update ⋅ August 17, 2019
	NEWS
	Quantbot Technologies LP Trimmed Gw Pharmaceuticals (GWPH) Position; International Business ... The EN Herald It is remarkable; 16/05/2018 – GW Pharmaceuticals: Epidiolex Reduced Monthly Frequency of Drop Seizures; 08/03/2018 Cannabidiol-infused ... Flag as irrelevant
	Scopia Capital Management LP Lowered Position in Gw Pharmaceuticals Plc (GWPH) by $100.07 ... The EN Herald ... INSYS Therapeutics Initiates Phase 2 Clinical Trial of Cannabidiol (CBD) for Treatment of Prader-Willi Syndrome; ... 19/04/2018 – FDA panel unanimously votes for GW Pharma's cannabis-derived epilepsy drug; 16/05/2018 – GW ... Flag as irrelevant
	As Align Technology (ALGN) Stock Declined, Shareholder Riverpark Advisors Cut Its Stake by ... Stocks Beat ... 16/05/2018 – Cannabidiol Significantly Reduces Seizures in Patients with Severe Form of Epilepsy; 08/05/2018 – GW PHARMACEUTICALS PLC ... Flag as irrelevant
	As Gw Pharmaceuticals Plc (GWPH) Share Value Declined, Holder Johnston Asset Management ... The NBO News ... 16/05/2018 – Cannabidiol Significantly Reduces Seizures in Patients with Severe Form of Epilepsy; 12/04/2018 – GW Pharmaceuticals and U.S. ... Flag as irrelevant
See more results | Edit this alert

You have received this email because you have subscribed to Google Alerts. Unsubscribe | View all your alerts

Receive this alert as RSS feed

Send Feedback